Inventor · disambiguated record
Elaine Liversidge
Also filed as: LIVERSIDGE ELAINE · LIVERSIDGE ELAINE M · LIVERSIDGE ELAINE MERISKO
15 granted patents·22 pending applications·2,736 citations·filing 1992–2021
95Inventor score
Files withELAN PHARMA INT LTD19ALKERMES PHARMA IRELAND LTD7EASTMAN KODAK CO2BOSCH H WILLIAM1FRANCHINI MIRIAM K1
Top patents by PatentIndex Score
37 records- 0198US5494683ASurface modified anticancer nanoparticlesEASTMAN KODAK CO·Filed 1994·Granted Feb 27, 1996·328 cites·4 claims
- 0298US5399363ASurface modified anticancer nanoparticlesEASTMAN KODAK CO·Filed 1992·Granted Mar 21, 1995·1k cites·17 claims
- 0397US5569448ASulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositionsNANO SYS LLC·Filed 1995·Granted Oct 29, 1996·338 cites·5 claims
- 0495USRE41884EReduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactionsELAN PHARMA INT LTD·Filed 2008·Granted Oct 26, 2010·26 cites·35 claims
- 0595US6270806B1Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositionsELAN PHARMA INT LTD·Filed 1999·Granted Aug 7, 2001·281 cites·49 claims
- 0695US5834025AReduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactionsNANOSYSTEMS LLC·Filed 1996·Granted Nov 10, 1998·173 cites·20 claims
- 0794US6267989B1Methods for preventing crystal growth and particle aggregation in nanoparticulate compositionsELAN PHARMA INT LTD·Filed 1999·Granted Jul 31, 2001·300 cites·31 claims
- 0893US7910577B2Injectable nanoparticulate olanzapine formulationsELAN PHARMA INT LTD·Filed 2005·Granted Mar 22, 2011·27 cites·17 claims
- 0993US5401492AWater insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agentsSTERLING WINTHROP INC·Filed 1992·Granted Mar 28, 1995·168 cites·7 claims
- 1086US7879360B2Nanoparticulate compositions having a peptide as a surface stabilizerELAN PHARMA INT LTD·Filed 2004·Granted Feb 1, 2011·30 cites·25 claims
- 1182US10849894B2Aripiprazole prodrug compositionALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Dec 1, 2020·1 cites·21 claims
- 1278US8258132B2Pharmaceutical composition of a tachykinin receptor antagonistBOSCH H WILLIAM·Filed 2002·Granted Sep 4, 2012·17 cites·10 claims
- 1375US2009155331A1Injectable nanoparticulate olanzapine formulationsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 1472US10688091B2Aripiprazole prodrug compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Jun 23, 2020·0 cites·21 claims
- 1572US10016415B2Aripiprazole prodrug compositionsALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Jul 10, 2018·1 cites·8 claims
- 1670US11154552B2Aripiprazole prodrug compositionALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Oct 26, 2021·0 cites·12 claims
- 1768US2013309310A1Injectable Nanoparticulate Olanzapine FormulationsALKERMES PHARMA IRELAND LTD·Filed 2013·Application pending·0 cites
- 1864US2009252806A1Nanoparticulate tacrolimus formulationsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 1961US2008152720A1Nanoparticulate tacrolimus formulationsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 2061US2007122486A1Nanoparticulate insulinELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2161US2015238505A1Injectable nanoparticulate olanzapine formulationsALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 2260US2012087984A1Stabilization of chemical compounds using nanoparticulate formulationsLIVERSIDGE ELAINE·Filed 2011·Application pending·0 cites
- 2359US2007224279A1Stabilization of chemical compounds using nanoparticulate formulationsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2457US2012315336A1Injectable nanoparticulate olanzapine formulationsRUDDY STEPHEN B·Filed 2012·Application pending·0 cites
- 2556US2022079939A1Aripiprazole prodrug compositionALKERMES PHARMA IRELAND LTD·Filed 2021·Application pending·0 cites
- 2655US2005147664A1Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent deliveryELAN PHARMA INT LTD·Filed 2004·Application pending·0 cites
- 2755US2006159766A1Nanoparticulate tacrolimus formulationsELAN PHARMA INT LTD·Filed 2005·Application pending·0 cites
- 2854US2004173696A1Milling microgram quantities of nanoparticulate candidate compoundsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 2953US2011027371A1Nanoparticulate statin formulations and novel statin combinationsELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3052US2003095928A1Nanoparticulate insulinELAN PHARMA INT LTD·Filed 2002·Application pending·0 cites
- 3151US2004018242A1Nanoparticulate nystatin formulationsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3249US2009175951A1Nanoparticulate compositions of immunosuppressive agentsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 3345US2011195095A1Injectable nanoparticulate olanzapine formulationsLIVERSIDGE GARY·Filed 2011·Application pending·0 cites
- 3445US2008213378A1Nanoparticulate statin formulations and novel statin combinationsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 3544US2006188566A1Nanoparticulate formulations of docetaxel and analogues thereofELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3637US2003054042A1Stabilization of chemical compounds using nanoparticulate formulationsFiled 2001·Application pending·0 cites
- 3733US2009004277A1Nanoparticle dispersion containing lactam compoundFRANCHINI MIRIAM K·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elaine Liversidge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →